torulene

Also Known As:

torulin

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Neoplasms (Cancer) 12/16/2017 - "Corrigendum to "The suppression of torulene and torularhodin treatment on the growth of PC-3 xenograft prostate tumors" [Biochem. " 01/22/2016 - "The suppression of torulene and torularhodin treatment on the growth of PC-3 xenograft prostate tumors." 01/22/2016 - "These results show that both torulene and torularhodin supplementation inhibit the growth of prostate cancer in nude mice and suggest that such an action is associated the apoptosis of tumor cells." 01/22/2016 - "The present study was to elucidate the anti-cancer activity of torulene and torularhodin in vivo with lycopene as a control. "
2.	Prostatic Neoplasms (Prostate Cancer) 01/22/2016 - "These results show that both torulene and torularhodin supplementation inhibit the growth of prostate cancer in nude mice and suggest that such an action is associated the apoptosis of tumor cells."
3.	Breast Neoplasms (Breast Cancer) 01/01/2022 - "This is the first report on anti-breast cancer activities, particularly targeting TNBC cells by red yeast carotenoids (β-carotene, torulene, and torularhodin) produced via a sustainable environment-friendly bioprocess utilizing waste hydrolysate."
4.	Body Weight (Weight, Body) 01/22/2016 - "Nude mice were orally supplemented every day with a low or high dose [9 or 18 mg/kg body weight (BW)] of lycopene, torularhodin or torulene. "